PF-3274167Oral oxytocin antagonist CAS# 900510-03-4 |
2D Structure
- Methylcobalamin
Catalog No.:BCC5188
CAS No.:13422-55-4
- Miglustat hydrochloride
Catalog No.:BCC5186
CAS No.:210110-90-0
- Tirapazamine
Catalog No.:BCC5184
CAS No.:27314-97-2
- Amifampridine
Catalog No.:BCC5185
CAS No.:54-96-6
- Miglustat
Catalog No.:BCC5187
CAS No.:72599-27-0
- Grape Seed Extract
Catalog No.:BCC5317
CAS No.:84929-27-1
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
Cas No. | 900510-03-4 | SDF | Download SDF |
PubChem ID | 11683187 | Appearance | Powder |
Formula | C19H19ClFN5O3 | M.Wt | 419.84 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Synonyms | cligosiban | ||
Solubility | DMSO : ≥ 50 mg/mL (119.09 mM) *"≥" means soluble, but saturation unknown. | ||
Chemical Name | 5-[3-[3-(2-chloro-4-fluorophenoxy)azetidin-1-yl]-5-(methoxymethyl)-1,2,4-triazol-4-yl]-2-methoxypyridine | ||
SMILES | COCC1=NN=C(N1C2=CN=C(C=C2)OC)N3CC(C3)OC4=C(C=C(C=C4)F)Cl | ||
Standard InChIKey | HNIFCPBQMKPRCX-UHFFFAOYSA-N | ||
Standard InChI | InChI=1S/C19H19ClFN5O3/c1-27-11-17-23-24-19(26(17)13-4-6-18(28-2)22-8-13)25-9-14(10-25)29-16-5-3-12(21)7-15(16)20/h3-8,14H,9-11H2,1-2H3 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | PF-3274167 is a high-affinity nonpeptide oxytocin receptor (OTR) antagonist, with Ki of 9.5 nM.
IC50 value: 9.5 nM [1]
Target: oxytocin receptor (OTR) References: |
PF-3274167 Dilution Calculator
PF-3274167 Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 2.3819 mL | 11.9093 mL | 23.8186 mL | 47.6372 mL | 59.5465 mL |
5 mM | 0.4764 mL | 2.3819 mL | 4.7637 mL | 9.5274 mL | 11.9093 mL |
10 mM | 0.2382 mL | 1.1909 mL | 2.3819 mL | 4.7637 mL | 5.9546 mL |
50 mM | 0.0476 mL | 0.2382 mL | 0.4764 mL | 0.9527 mL | 1.1909 mL |
100 mM | 0.0238 mL | 0.1191 mL | 0.2382 mL | 0.4764 mL | 0.5955 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
PF-3274167 is an oral oxytocin antagonist.
- Inulin
Catalog No.:BCC4789
CAS No.:9005-80-5
- Ylangenyl acetate
Catalog No.:BCN6704
CAS No.:90039-63-7
- Detomidine HCl
Catalog No.:BCC4346
CAS No.:90038-01-0
- PFI 4
Catalog No.:BCC6484
CAS No.:900305-37-5
- Agar (bacteriological)
Catalog No.:BCC1208
CAS No.:9002-18-0
- PIK-294
Catalog No.:BCC4995
CAS No.:900185-02-6
- PIK-293
Catalog No.:BCC4994
CAS No.:900185-01-5
- Boc-Ser(PO3Bzl2)-OH
Catalog No.:BCC3443
CAS No.:90013-45-9
- 4,4'-Bis(diethylamino)benzophenone
Catalog No.:BCC8659
CAS No.:90-93-7
- Lobelin
Catalog No.:BCN2157
CAS No.:90-69-7
- 6-Amino-4-hydroxy-2-naphthalenesulfonic acid
Catalog No.:BCC8761
CAS No.:90-51-7
- 3,4,5-Trimethoxycinnamic acid
Catalog No.:BCN5030
CAS No.:90-50-6
- AS-252424
Catalog No.:BCC4988
CAS No.:900515-16-4
- 5-O-beta-D-Glucopyranosylmyricanol
Catalog No.:BCN8044
CAS No.:90052-02-1
- Chondroitin sulfate
Catalog No.:BCN1312
CAS No.:9007-28-7
- AVX 13616
Catalog No.:BCC5407
CAS No.:900814-48-4
- Rebamipide
Catalog No.:BCC4836
CAS No.:90098-04-7
- TAME
Catalog No.:BCC4367
CAS No.:901-47-3
- Fostamatinib (R788)
Catalog No.:BCC5082
CAS No.:901119-35-5
- GSK 5959
Catalog No.:BCC5597
CAS No.:901245-65-6
- Gossypolone
Catalog No.:BCC1375
CAS No.:4547-72-2
- AT7519 Hydrochloride
Catalog No.:BCC1376
CAS No.:902135-91-5
- NVP-LCQ195
Catalog No.:BCC1816
CAS No.:902156-99-4
- UBP 310
Catalog No.:BCC6052
CAS No.:902464-46-4
[(11)C]PF-3274167 as a PET radiotracer of oxytocin receptors: Radiosynthesis and evaluation in rat brain.[Pubmed:28917111]
Nucl Med Biol. 2017 Dec;55:1-6.
INTRODUCTION: Oxytocin plays a major role in the regulation of social interactions in mammals by interacting with the oxytocin receptor (OTR) expressed in the brain. Furthermore, the oxytocin system appears as a possible therapeutic target in autism spectrum disorders and other psychiatric troubles, justifying current pharmacological researches. Since no specific PET radioligand is currently available to image OTR in the brain, the aim of this study was to radiolabel the specific OTR antagonist PF-3274167 and to evaluate [(11)C]PF-3274167 as a potential PET tracer for OTR in rat brains. METHODS: [(11)C]PF-3274167 was prepared via the O-methylation of its desmethyl precursor with [(11)C]methyl iodide. The lipophilicity of the radioactive compound was evaluated by measuring the n-octanol-buffer partition coefficient (logD). Autoradiography experiments were performed on rat brain tissue to evaluate the in vitro distribution of the [(11)C]PF-3274167. MicroPET experiments were conducted with and without pre-injection of ciclosporin in order to evaluate the influence of the P-glycoprotein (P-gp) on the brain uptake. RESULTS: [(11)C]PF-3274167 was synthesized with high radiochemical and chemical purities (>95%) and good specific activity. The measured logD was 1.93. In vitro, [(11)C]PF-3274167 did not show any evidence of specific binding to OTR. PET imaging showed that [(11)C]PF-3274167 uptake in rat brain was very low in basal conditions but increased significantly after the administration of ciclosporin, suggesting that it is a substrate of the P-gp. In the ciclosporin-pre-injected rat, however, [(11)C]PF-3274167 distribution did not match with the known distribution of OTR in rats. CONCLUSION: [(11)C]PF-3274167 is not a suitable tracer for imaging of OTR in rat brain, probably because of a too low affinity for this receptor in addition to a poor brain penetration.